CHRISTOPHER PATUSKY - 13 Jul 2023 Form 4 Insider Report for UNITED THERAPEUTICS Corp (UTHR)

Role
Director
Signature
/s/ John S. Hess, Jr. under Power of Attorney
Issuer symbol
UTHR
Transactions as of
13 Jul 2023
Net transactions value
$0
Form type
4
Filing time
17 Jul 2023, 06:30:13 UTC
Previous filing
11 May 2023
Next filing
18 Aug 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction UTHR Stock Options Award $0 +2,280 $0.000000 2,280 13 Jul 2023 Common Stock 2,280 $229.81 Direct F1, F2
transaction UTHR Restricted Stock Unit Award $0 +900 $0.000000 900 13 Jul 2023 Common Stock 900 $0.000000 Direct F1, F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Annual non-employee director award.
F2 These awards vest on the one-year anniversary of the grant date only if the reporting person attends at least 75% of the regularly scheduled meetings of the issuer's Board and his or her committee meetings from the date of grant until the date of the issuer's next annual meeting of shareholders.
F3 Each restricted stock unit represents the right to receive, following vesting, one share of United Therapeutics Corporation common stock.
F4 Not applicable as restricted stock units do not have an expiration date.